Compass Therapeutics
CMPX
CMPX
76 hedge funds and large institutions have $177M invested in Compass Therapeutics in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 30 increasing their positions, 19 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
1.13% less ownership
Funds ownership: 71.52% → 70.39% (-1.1%)
39% less capital invested
Capital invested by funds: $288M → $177M (-$111M)
Holders
76
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$868K | |
| 2 | +$372K | |
| 3 | +$282K | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$256K |
| 5 |
Goldman Sachs
New York
|
+$222K |
Top Sellers
| 1 | -$1.94M | |
| 2 | -$1.46M | |
| 3 | -$293K | |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
-$257K |
| 5 |
FCMV
Foresite Capital Management V
Larkspur,
California
|
-$152K |